Farringdon Capital, Ltd.
Source: SEC Form 13F · as of Mar 2026Farringdon Capital, Ltd. holds 20 biotech & pharma companies tracked by BioSniper, totaling $21.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$21.0M
| Company | Shares | Value |
|---|---|---|
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 69,914 | $3.9M |
| PFEPFIZER INC | 82,058 | $2.3M |
| IQVIQVIA Holdings Inc. | 12,535 | $2.1M |
| LLYELI LILLY & Co | 1,877 | $1.7M |
| BIIBBIOGEN INC. | 9,054 | $1.7M |
| CORCencora Inc. | 5,244 | $1.6M |
| MRKMerck & Co., Inc. | 9,120 | $1.1M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1,831 | $818K |
| AZNASTRAZENECA PLC | 4,084 | $805K |
| IDXXIDEXX LABORATORIES INC /DE | 1,340 | $753K |
| JNJJOHNSON & JOHNSON | 2,938 | $718K |
| PMPhilip Morris International Inc | 4,043 | $668K |
| MOHMolina Healthcare Inc | 3,847 | $513K |
| ABTABBOTT LABORATORIES | 4,315 | $443K |
| NVONovo Nordisk A/S | 11,598 | $426K |
| NBIXNEUROCRINE BIOSCIENCES INC | 3,211 | $423K |
| DGXQuest Diagnostics Incorporated | 1,583 | $310K |
| DVADaVita Inc. | 1,730 | $266K |
| WSTWest Pharmaceutical Services Inc. | 966 | $242K |
| JAZZJazz Pharmaceuticals plc | 1,092 | $206K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.